Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is not a dichotomous
disease trait. Technological innovations enable long-term rhythm monitoring in many …

Automated continuous rhythm monitoring has been made possible with the extensive use of
cardiac implantable electronic devices (CIEDs). A highly prevalent finding in devices with …

Aim Reduced left atrial PITX2 is associated with atrial cardiomyopathy and atrial fibrillation.
PITX2 is restricted to left atrial cardiomyocytes in the adult heart. The links between PITX2 …

Aims The aim is to describe the rationale, design, delivery, and baseline characteristics of
the Stroke prevention and rhythm control Treatment: Evaluation of an Educational …

Aims Anticoagulation can prevent stroke and prolong lives in patients with atrial fibrillation
(AF). However, anticoagulated patients with AF remain at risk of death. The aim of this study …

Abstract Background and Aims In patients with atrial fibrillation (AF), recurrent AF and sinus
rhythm during follow-up are determined by interactions between cardiovascular disease …

Aims Recommendations on cardiac resynchronization therapy (CRT) in patients with atrial
fibrillation or flutter (AF) are based on less robust evidence than those in sinus rhythm (SR) …

Background: Achieving early rhythm control and maintaining sinus rhythm are associated
with improved outcomes in patients with atrial fibrillation (AF). Pulmonary vein isolation (PVI) …

Aims Atrial fibrillation (AF) is the most common type of cardiac arrythmia and is an important
risk factor for ischaemic stroke. Many cases of AF remain undiagnosed due to its …

Background and aims The optimal antithrombotic therapy in patients with device-detected
atrial fibrillation (DDAF) is unknown. Concomitant vascular disease can modify the benefits …